Teleflex, Inc. (TFX)
155.04
+1.89
(+1.23%)
USD |
NYSE |
Nov 13, 16:00
155.04
0.00 (0.00%)
After-Hours: 19:59
Teleflex Enterprise Value : 7.440B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.440B |
| November 11, 2026 | 7.569B |
| November 10, 2026 | 7.527B |
| November 09, 2026 | 7.504B |
| November 06, 2026 | 7.348B |
| November 05, 2026 | 7.400B |
| November 04, 2026 | 7.308B |
| November 03, 2026 | 6.906B |
| November 02, 2026 | 6.935B |
| October 30, 2026 | 6.899B |
| October 29, 2026 | 6.964B |
| October 28, 2026 | 6.867B |
| October 27, 2026 | 6.868B |
| October 26, 2026 | 6.779B |
| October 23, 2026 | 6.758B |
| October 22, 2026 | 6.770B |
| October 21, 2026 | 6.519B |
| October 20, 2026 | 6.550B |
| October 19, 2026 | 6.490B |
| October 16, 2026 | 6.521B |
| October 15, 2026 | 6.431B |
| October 14, 2026 | 6.232B |
| October 13, 2026 | 6.278B |
| October 12, 2026 | 6.329B |
| October 09, 2026 | 6.306B |
| Date | Value |
|---|---|
| October 08, 2026 | 6.268B |
| October 07, 2026 | 6.280B |
| October 06, 2026 | 6.290B |
| October 05, 2026 | 6.311B |
| October 02, 2026 | 6.265B |
| October 01, 2026 | 6.346B |
| September 30, 2026 | 6.302B |
| September 29, 2026 | 7.910B |
| September 28, 2026 | 7.955B |
| September 25, 2026 | 7.730B |
| September 24, 2026 | 7.646B |
| September 23, 2026 | 7.716B |
| September 22, 2026 | 7.850B |
| September 21, 2026 | 7.846B |
| September 18, 2026 | 7.834B |
| September 17, 2026 | 7.879B |
| September 16, 2026 | 7.981B |
| September 15, 2026 | 8.025B |
| September 14, 2026 | 8.079B |
| September 11, 2026 | 8.108B |
| September 10, 2026 | 8.151B |
| September 09, 2026 | 8.308B |
| September 08, 2026 | 8.363B |
| September 04, 2026 | 8.420B |
| September 03, 2026 | 8.488B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.182B |
| Penumbra, Inc. | 12.18B |
| Abbott Laboratories | 213.21B |
| Becton, Dickinson & Co. | 74.08B |
| Boston Scientific Corp. | 75.60B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.29M |
| Revenue (Quarterly) | 567.78M |
| Total Expenses (Quarterly) | 513.50M |
| EPS Diluted (Quarterly) | 22.28 |
| Gross Profit Margin (Quarterly) | 64.58% |
| Profit Margin (Quarterly) | 9.56% |
| Earnings Yield | 5.31% |
| Operating Earnings Yield | 4.14% |
| Normalized Earnings Yield | 5.982 |